NA
ANGO icon

NewEdge Advisors’s AngioDynamics ANGO Stock Holding History

NewEdge Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-450
Closed -$5.78K – 4139
2025
Q4 		$5.78K Buy
+450
New +$5.55K ﹤0.01% 3636
2025
Q1 		– Sell
-20
Closed -$183 – 3958
2024
Q4 		$183 Hold
20
– – ﹤0.01% 3747
2024
Q3 		$156 Hold
20
– – ﹤0.01% 3694
2024
Q2 		$121 Sell
20
-633
-97% -$3.91K ﹤0.01% 3681
2024
Q1 		$3.83K Sell
653
-531
-45% -$3.15K ﹤0.01% 3231
2023
Q4 		$9.28K Buy
+1,184
New +$8.21K ﹤0.01% 2886
2023
Q1 		– Sell
-60
Closed -$826 – 3440
2022
Q4 		$826 Buy
+60
New +$835 ﹤0.01% 3084

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

NewEdge Advisors's ANGO Position: Q1 2026 in Review

NewEdge Advisors sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 450 shares — an estimated $5.78K sold.

NewEdge Advisors first reported a position in ANGO in Q4 2022 and held it in 7 quarters. The position peaked at $9.28K in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • NewEdge Advisors reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • NewEdge Advisors sold 450 AngioDynamics shares in Q1 2026, an estimated $5.78K.
  • NewEdge Advisors first reported a position in AngioDynamics in Q4 2022 and held it in 7 quarters.
  • NewEdge Advisors's AngioDynamics position peaked at $9.28K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.